Whether your focus is on compounds or biological samples, IQPC's Compound & Sample Management Summit, August 29-31 in Philadelphia, offers a key round-up of industry best practice and a forecast for the future.
As sponsors, Titian Software offer you a special 20% discount on your event pass: simply quote 'CSM_SPONSOR' when you register here.
We have prepared the following essential guide to the best of the 2016 programme, so you are in the know before you go:
Monday 29 August – optional Workshop day
11:30 Workshop B: Next generation automation technology: integrating the latest equipment into your lab
Matt Boeckler, AstraZeneca, guides you through
- Learning how advanced automation can affect processes, from early discovery to clinical diagnostics
- Preparing a cost analysis for adding new automation
- Exploring the impact on scientists’ workflows
Tuesday 30 August
9:00 Keynote address: Defining a holistic sample management organization for the 21st Century
Susan Crimmin, GlaxoSmithKline, gives key insights on how to:
- Modernize your current platforms in growing areas such as biologics
- Recognize synergies and differences between biological & small molecule sample management
- Acknowledge the big picture perspective
9:45 New Case Study The evolution of compound management at Bristol-Myers Squibb – How they built stability into an unpredictable future
Victoria Emerick, Bristol-Myers Squibb, discusses:
- Change management for moving the compound management operations team across sites
- Strategies for a comprehensive overhaul of obsolete infrastructure
- Future-proof capital investment and the functional value of an integrated sample management team
10:30 Technology Demo Drive
Learn about the latest and most innovative technologies available in the industry and test drive Titian’s SampleBank™ sample management software for yourself!
11.15 Panel Discussion: Maximizing your compound & sample usage: a discussion on waste reduction from both the small molecule and biological sample drug discovery perspectives.
Chaired by Matt Boeckler, AstraZeneca and MaryBeth Burton, Merck
13.45 Case Study: Ensuring data quality in an outsourcing environment: how Epizyme conducted detailed CRO site checks on a global scale
Elizabeth Admirand, Epizyme, recalls:
- Stringent site checks that revealed multiple discrepancies in compound management
- Red flags to look for during written and in-person communication with CRO’s
- How to fine-tune outsourced site processes to ensure data integrity during tech transfers
Wednesday 31 August
09:00 Keynote: The direct impact of compound and sample management on lead discovery through to clinical trials: An in-depth look at how St. Jude Children’s Research Hospital leverages state of the art innovations to find cures for paediatric cancer and other catastrophic diseases
Julianne Bryan, St Jude Children’s Research Hospital, discusses how to:
- Use data from combination studies to advance research decisions
- Tools to adapt your compound management processes for more customized screens
- Take ownership of your translational research
14:00 Panel Discussion: Strategies for engaging & retaining your compound & sample management team
Chair: Matt Boeckeler, AstraZeneca, helps to explore the varying challenges between small and large organizations regarding employee engagement.
15:45 Discussion Groups
Table 3: Best Practices for shipping biological samples on a global scale
And don’t forget:
Drop by Titian's conference booth to discuss your sample management requirements and industry best practice or get in touch with Titian's sample management experts.